Therapeutic Effect of Gastrografin and Predictors of Operative Intervention in Patients with Adhesive Small Bowel Obstruction: A Randomized Controlled Study

Overview

Journal Turk J Surg

Specialty General Surgery

Date 2020 Jun 19

PMID 32550318

Authors

Hamid Reza Khorshidi

Parviz Majidi

Azar Pirdehghan

Affiliations

Soon will be listed here.

Abstract

Objectives: The study aimed to investigate the therapeutic effect of gastrografin for the conservative treatment of patients with adhesive small bowel obstruction (ASBO) and to identify the predictors of failure of conservative treatment in these patients.

Material And Methods: A randomized controlled trial was conducted on 52 patients with the diagnosis of ASBO in 2016. 100 mL of Gastrografin and 100 mL of 0.9% saline solution were gavaged through the nasogastric tube in the case (n= 26) and control (n= 26) groups, respectively. Patients in the case group were subjected to plain abdominal X-Rays at 12, 24 and 48 hours after administration of gastrografin.

Results: Fifty-two patients with a mean age of 57.6 ± 11.4 years (range 37-81), including 34 (65.4%) males were enrolled into the study. The number of patients who were successfully conservatively treated in the case group was 21 (80.8%), which was significantly higher than 13 (50%) in the control group (p= 0.04). Among these patients, mean hospital stay in the case group was 37.2 ± 5.5 hours (range 28-46), which was significantly shorter than 45.8 ± 9.2 hours (range 36-61) in the control group (p= 0.004). In multivariate analysis, more than one previous laparotomy was the only predictor of failure of conservative treatment (p <0.001).

Conclusion: Gastrografin may be associated with improvement of patients with ASBO. Lower number of previous laparotomies may be a predictor of successful conservative treatment of these patients.

References

Zielinski M, Haddad N, Cullinane D, Inaba K, Yeh D, Wydo S . Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction. J Trauma Acute Care Surg. 2017; 83(1):47-54. DOI: 10.1097/TA.0000000000001499. View

Di Saverio S, Coccolini F, Galati M, Smerieri N, Biffl W, Ansaloni L . Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2013; 8(1):42. PMC: 4124851. DOI: 10.1186/1749-7922-8-42. View

Catena F, Di Saverio S, Kelly M, Biffl W, Ansaloni L, Mandala V . Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2011; 6:5. PMC: 3037327. DOI: 10.1186/1749-7922-6-5. View

Ellis H, Moran B, Thompson J, Parker M, Wilson M, Menzies D . Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999; 353(9163):1476-80. DOI: 10.1016/S0140-6736(98)09337-4. View

Burge J, Abbas S, Roadley G, Donald J, Connolly A, Bissett I . Randomized controlled trial of Gastrografin in adhesive small bowel obstruction. ANZ J Surg. 2005; 75(8):672-4. DOI: 10.1111/j.1445-2197.2005.03491.x. View

Scotte M, Mauvais F, Bubenheim M, Cosse C, Suaud L, Savoye-Collet C . Use of water-soluble contrast medium (gastrografin) does not decrease the need for operative intervention nor the duration of hospital stay in uncomplicated acute adhesive small bowel obstruction? A multicenter, randomized, clinical trial (Adhesive.... Surgery. 2017; 161(5):1315-1325. DOI: 10.1016/j.surg.2016.11.026. View

Ceresoli M, Coccolini F, Montori G, Sartelli M, Catena F, Ansaloni L . Water-soluble contrast agent in adhesive small bowel obstruction: the game is still on. Surgery. 2017; 162(1):199-200. DOI: 10.1016/j.surg.2017.01.017. View

Feigin E, Seror D, Szold A, Carmon M, Allweis T, Nissan A . Water-soluble contrast material has no therapeutic effect on postoperative small-bowel obstruction: results of a prospective, randomized clinical trial. Am J Surg. 1996; 171(2):227-9. DOI: 10.1016/S0002-9610(97)89553-0. View

Van Der Krabben A, Dijkstra F, Nieuwenhuijzen M, Reijnen M, Schaapveld M, van Goor H . Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg. 2000; 87(4):467-71. DOI: 10.1046/j.1365-2168.2000.01394.x. View

10.

Abbas S, Bissett I, Parry B . Meta-analysis of oral water-soluble contrast agent in the management of adhesive small bowel obstruction. Br J Surg. 2007; 94(4):404-11. DOI: 10.1002/bjs.5775. View

11.

Bueno-Lledo J, Barber S, Vaque J, Frasson M, Garcia-Granero E, Juan-Burgueno M . Adhesive Small Bowel Obstruction: Predictive Factors of Lack of Response in Conservative Management with Gastrografin. Dig Surg. 2015; 33(1):26-32. DOI: 10.1159/000441530. View

12.

Biondo S, Pares D, Mora L, Marti Rague J, Kreisler E, Jaurrieta E . Randomized clinical study of Gastrografin administration in patients with adhesive small bowel obstruction. Br J Surg. 2003; 90(5):542-6. DOI: 10.1002/bjs.4150. View

13.

Rahmani N, Mohammadpour R, Khoshnood P, Ahmadi A, Assadpour S . Prospective evaluation of oral gastrografin(®) in the management of postoperative adhesive small bowel obstruction. Indian J Surg. 2014; 75(3):195-9. PMC: 3689375. DOI: 10.1007/s12262-012-0479-7. View

14.

Zielinski M, Eiken P, Bannon M, Heller S, Lohse C, Huebner M . Small bowel obstruction-who needs an operation? A multivariate prediction model. World J Surg. 2010; 34(5):910-9. PMC: 4882094. DOI: 10.1007/s00268-010-0479-3. View

15.

Haule C, Ongom P, Kimuli T . Efficacy of Gastrografin Compared with Standard Conservative Treatment in Management of Adhesive Small Bowel Obstruction at Mulago National Referral Hospital. J Clin Trials. 2014; 3(4). PMC: 3982137. DOI: 10.4172/2167-0870.1000144. View

16.

Miquel J, Biondo S, Kreisler E, Uribe C, Trenti L . Failure of conservative treatment with Gastrografin® for adhesive small bowel obstruction after colorectal surgery. Int J Colorectal Dis. 2017; 32(7):1051-1055. DOI: 10.1007/s00384-017-2786-8. View

17.

Komatsu I, Tokuda Y, Shimada G, Jacobs J, Onodera H . Development of a simple model for predicting need for surgery in patients who initially undergo conservative management for adhesive small bowel obstruction. Am J Surg. 2010; 200(2):215-23. DOI: 10.1016/j.amjsurg.2009.07.045. View

18.

Choi H, Chu K, Law W . Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial. Ann Surg. 2002; 236(1):1-6. PMC: 1422541. DOI: 10.1097/00000658-200207000-00002. View

19.

Miller G, Boman J, Shrier I, Gordon P . Etiology of small bowel obstruction. Am J Surg. 2000; 180(1):33-6. DOI: 10.1016/s0002-9610(00)00407-4. View

20.

Fevang B, Jensen D, Fevang J, Sondenaa K, Ovrebo K, Rokke O . Upper gastrointestinal contrast study in the management of small bowel obstruction--a prospective randomised study. Eur J Surg. 2000; 166(1):39-43. DOI: 10.1080/110241500750009681. View